BIOMED CONSULTING AS

3183 HORTEN

Finances

Return on Equity

26 %

Current Ratio

11,42

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	1 348 000	1 129 000	925 000	181 000
Net Income	897 000	622 000	590 000	−30 000
Total Assets	3 780 000	2 815 000	2 396 000	1 591 000
Total Equity	3 450 000	2 553 000	2 180 000	1 591 000

Income (NOK)	2022	2021	2020	2019
Revenue	1 348 000	1 129 000	925 000	181 000
Expenditure	160 000	81 000	171 000	136 000
Operating Profit	1 188 000	1 049 000	755 000	45 000
Financial Income	2 000	2 000	1 000	2 000
Financial Costs	32 000	197 000	0	71 000
Financial Balance	−30 000	−195 000	1 000	−69 000
Earnings Before Tax	1 158 000	853 000	756 000	−24 000
Tax	261 000	231 000	166 000	5 000
Net Income	897 000	622 000	590 000	−30 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	0	0	583 000	143 000
Total Current Assets	3 780 000	2 815 000	1 813 000	1 448 000
Total Assets	3 780 000	2 815 000	2 396 000	1 591 000
Total Retained Equity	3 350 000	2 453 000	2 080 000	1 491 000
Total Equity	3 450 000	2 553 000	2 180 000	1 591 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	331 000	262 000	216 000	1 000
Total Equity and Debt	3 780 000	2 815 000	2 396 000	1 591 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	1 348 000	1 129 000	925 000	181 000
Other Income	0	0	0	0
Revenue	1 348 000	1 129 000	925 000	181 000
Cost of Goods Sold	0	0	11 000	0
Salary Costs	4 000	1 000	1 000	0
Depreciation	0	0	0	0
Impairment	0	0	0	0
Expenditure	160 000	81 000	171 000	136 000
Operating Profit	1 188 000	1 049 000	755 000	45 000
Financial Income	2 000	2 000	1 000	2 000
Financial Costs	32 000	197 000	0	71 000
Financial Balance	−30 000	−195 000	1 000	−69 000
Dividends	0	0	0	0
Net Income	897 000	622 000	590 000	−30 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	0	0
Total Tangible Assets	0	0	0	0
Total Fiancial Fixed Assets	0	0	583 000	143 000
Total Fixed Assets	0	0	583 000	143 000
Stock	0	0	0	0
Total Investments	654 000	686 000	0	2 000
Cash, Bank	3 119 000	2 129 000	1 811 000	1 446 000
Total Current Assets	3 780 000	2 815 000	1 813 000	1 448 000
Total Assets	3 780 000	2 815 000	2 396 000	1 591 000
Total Equity	3 450 000	2 553 000	2 180 000	1 591 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	0	0
Creditors	2 000	0	0	0
Unpaid Taxes	63 000	31 000	43 000	−5 000
Dividends	0	0	0	0
Other Current Debt	4 000	0	7 000	0
Total Current Debt	331 000	262 000	216 000	1 000
Total Equity and Debt	3 780 000	2 815 000	2 396 000	1 591 000

Financial indicators	2022	2021	2020	2019
Return on Equity	26 %	24,36 %	27,06 %	−1,89 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	88,13 %	92,91 %	81,62 %	24,86 %
Current Ratio	11,42	10,74	8,39	1 448
Quick Ratio	11,42	10,74	8,39	1 448
Equity Ratio	0,91	0,91	0,91	1
Gross Profit Margin	100 %	100 %	98,81 %	100 %